Clinical Trial Update: Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing Respimat Budesonide with Turbohaler Budesonide in symptomatic adult asthma patients on inhaled corticosteroids and bronchodil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Respimat Budesonide (Budesonide)
• Turbohaler Budesonide (Budesonide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 3 | Status: COMPLETED